Kalcioglu M Tayyar, Bayindir Tuba, Erdem Tamer, Ozturan Orhan
Department of Otorhinolaryngology; Inonu University, School of Medicine, Turgut Ozal Medical Center, Malatya 44069, Turkey.
Hear Res. 2005 Jan;199(1-2):81-8. doi: 10.1016/j.heares.2004.08.004.
Tinnitus is one of the most common and distressing otological symptoms. Although numerous therapeutic modalities have been tried, there is no consensus regarding effective therapeutic agents up to now. The effects of lidocaine on tinnitus have been reported in literature using either subjective or audiologic tests. Nevertheless, the otoacoustic emissions (OAEs) have not been utilized to demonstrate lidocaine's effect on the cochlea in the English literature. The aim of this study was to evaluate the effect of lidocaine on tinnitus by considering the alterations with tinnitus, it induces on OAEs and subjective symptoms.
This study was performed in 30 patients with tinnitus. Twenty-eight of the patients had normal hearing and two of them evidenced mild sensorineural hearing loss. To determine the severity of tinnitus, the patients were required to fill out a tinnitus scoring scale before lidocaine infusion on the same day. Then, lidocaine was administered intravenously to each patient at a dose of 1.5 mg/kg body weight over a period of 30 min. Spontaneous otoacoustic emissions (SOAEs) and distortion product otoacoustic emissions (DPOAEs) were measured three times; namely before lidocaine injection, at 25 min after injection and on the next day. The severity of tinnitus was scored again 1 d, 1 wk and 1 mo after lidocaine administration.
Immediately after infusion, four patients (13.3%) declared total suppression of tinnitus, whereas three patients (10%) reported only partial relief in tinnitus subjectively. The patients, who had a subjective improved response (group 1) were compared with the patients, who had no response (group 2). Statistically significant changes (p<0.05) in DPOAE response/growth or input/output (I/O) functions were observed at 1, 2, 3, 4 and 6 kHz frequencies in lidocaine responders and at 1, 2, 3, 4 and 5 kHz frequencies in no responders at different primary stimulus levels. Statistically significant changes (p<0.05) were seen at 2 kHz for 53 dB and at 3 kHz for 62 dB SPL primaries in both groups. When the significant results of these two groups were compared with each other, differences were found insignificant.
Systematic OAE measurements revealed that no changes occurred in SOAE and DPOAE levels in that alterations disappeared the next day. Subjective relief from tinnitus was stated in some of the patients and lasted for 4 wk at longest.
耳鸣是最常见且令人苦恼的耳科症状之一。尽管已经尝试了多种治疗方法,但迄今为止,关于有效的治疗药物尚无共识。利多卡因对耳鸣的影响已在文献中通过主观或听力学测试进行了报道。然而,在英文文献中,尚未利用耳声发射(OAE)来证明利多卡因对耳蜗的作用。本研究的目的是通过考虑耳鸣引起的变化、其对耳声发射和主观症状的影响,来评估利多卡因对耳鸣的作用。
本研究对30例耳鸣患者进行。其中28例听力正常,2例有轻度感音神经性听力损失。为了确定耳鸣的严重程度,要求患者在同一天利多卡因输注前填写耳鸣评分量表。然后,以1.5mg/kg体重的剂量在30分钟内静脉给予每位患者利多卡因。分别在利多卡因注射前、注射后25分钟和次日测量三次自发性耳声发射(SOAE)和畸变产物耳声发射(DPOAE)。在利多卡因给药后1天、1周和1个月再次对耳鸣严重程度进行评分。
输注后立即有4例患者(13.3%)称耳鸣完全消失,而3例患者(10%)主观上仅报告耳鸣部分缓解。将有主观改善反应的患者(第1组)与无反应的患者(第2组)进行比较。在不同的初始刺激水平下,利多卡因反应者在1、2、3、4和6kHz频率以及无反应者在1、2、3、4和5kHz频率的DPOAE反应/增长或输入/输出(I/O)功能有统计学显著变化(p<0.05)。两组在初始刺激声压级为53dB的2kHz频率和62dB SPL的3kHz频率处均有统计学显著变化(p<0.05)。当将这两组的显著结果相互比较时,发现差异不显著。
系统性耳声发射测量显示,SOAE和DPOAE水平未发生变化,因为这些变化在次日消失。部分患者称耳鸣主观缓解,最长持续4周。